至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

LncRNA OIP5-AS1 modulates the proliferation and apoptosis of Jurkat cells by sponging miR-181c-5p to regulate IL-7 expression in myasthenia gravis

PeerJ. 2022-05; 
Xu Wang, Huixue Zhang, Xiaoyu Lu, Shuang Li, Xiaotong Kong, Li Liu, Lifang Li, Si Xu, Tianfeng Wang, Jianjian Wang, Lihua Wang
Products/Services Used Details Operation
Gene Synthesis … ) and its negative control (shRNA-NC), miR-181c-5p mimics and its negative control, and miR-181c-5p inhibitor and its negative control were designed and synthesized by GenScript (… Get A Quote

摘要

unassigned: Myasthenia gravis (MG) is an antibody-mediated autoimmune disease. In recent years, accumulating evidence has indicated that long non-coding RNAs (lncRNAs) can function as competing endogenous RNAs (ceRNAs), contributing to the progression of various autoimmune diseases. Nevertheless, the regulatory roles of ceRNAs in MG pathogenesis remain unclear. In this study, we aimed to elucidate the role of lncRNA OIP5-AS1 as a ceRNA associated with MG progression. unassigned: Real-time PCR was used to detect OIP5-AS1 levels in peripheral blood mononuclear cells (PBMCs) from patients with MG. Luciferase reporter assays were performed to validate the relationship between OIP5-AS1 and miR-181c-5p. CCK-8 and flo... More

关键词

Competing endogenous RNA (ceRNA), IL-7, Myasthenia gravis (MG), OIP5-AS1, miR-181c-5p